These drugs can cross the blood-brain barrier (BBB), enhance hippocampal neurogenesis, and increase brain-derived neurotrophic factor (BDNF) expression, promoting neuroprotection in AD and PD [63, 64]. This evidence concerns the gene BDNF and Alzheimer disease.